Literature DB >> 15931385

Understanding globin regulation in beta-thalassemia: it's as simple as alpha, beta, gamma, delta.

Arthur Bank1.   

Abstract

A vast excess of alpha-globin production and inadequate gamma-globin compensation lead to the development of severe anemia in human beta-thalassemia. Newly identified modifiers of alpha- and gamma-globin synthesis and insights into the mechanisms of globin regulation provide the tools for potential new approaches to treating this and other red blood cell disorders. In the study by Han and colleagues in this issue of the JCI, the activity of a heme-regulated protein, HRI, is shown to modulate the accumulation of excess alpha-globin chains in murine beta-thalassemia and to decrease the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931385      PMCID: PMC1137010          DOI: 10.1172/JCI25398

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Multiple interactions between regulatory regions are required to stabilize an active chromatin hub.

Authors:  George P Patrinos; Mariken de Krom; Ernie de Boer; An Langeveld; A M Ali Imam; John Strouboulis; Wouter de Laat; Frank G Grosveld
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

2.  Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.

Authors:  Christopher R Vakoc; Danielle L Letting; Nele Gheldof; Tomoyuki Sawado; M A Bender; Mark Groudine; Mitchell J Weiss; Job Dekker; Gerd A Blobel
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

3.  A DNA-binding factor in adult hematopoietic cells interacts with a pyrimidine-rich domain upstream from the human delta-globin gene.

Authors:  D O'Neill; K Bornschlegel; M Flamm; M Castle; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

4.  Multiple hematopoietic defects and delayed globin switching in Ikaros null mice.

Authors:  Rocio A Lopez; Stuti Schoetz; Kathryn DeAngelis; David O'Neill; Arthur Bank
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia.

Authors:  An-Ping Han; Mark D Fleming; Jane-Jane Chen
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression.

Authors:  Lyubomira Chakalova; Cameron S Osborne; Yan-Feng Dai; Beatriz Goyenechea; Anna Metaxotou-Mavromati; Antonios Kattamis; Christos Kattamis; Peter Fraser
Journal:  Blood       Date:  2004-11-09       Impact factor: 22.113

Review 7.  Inhibition of histone deacetylase activity by butyrate.

Authors:  James R Davie
Journal:  J Nutr       Date:  2003-07       Impact factor: 4.798

Review 8.  Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?

Authors:  James S Chen; Douglas V Faller; Remco A Spanjaard
Journal:  Curr Cancer Drug Targets       Date:  2003-06       Impact factor: 3.428

9.  An abundant erythroid protein that stabilizes free alpha-haemoglobin.

Authors:  Anthony J Kihm; Yi Kong; Wei Hong; J Eric Russell; Susan Rouda; Kazuhiko Adachi; M Celeste Simon; Gerd A Blobel; Mitchell J Weiss
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

10.  Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia.

Authors:  Yi Kong; Suiping Zhou; Anthony J Kihm; Anne M Katein; Xiang Yu; David A Gell; Joel P Mackay; Kazuhiko Adachi; Linda Foster-Brown; Calvert S Louden; Andrew J Gow; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

View more
  3 in total

Review 1.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

2.  Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism.

Authors:  Cynthia K Hahn; Christopher H Lowrey
Journal:  Blood       Date:  2013-05-20       Impact factor: 22.113

Review 3.  What Is Next in This "Age" of Heme-Driven Pathology and Protection by Hemopexin? An Update and Links with Iron.

Authors:  Luis Montecinos; Jeffrey D Eskew; Ann Smith
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.